Form 4 for ZLAB Zai Lab Ltd
Accepted 2023-06-30 00:00:00 ET · period of report 2023-06-29 · accession 0000950170-23-031099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-06-29 | ZLAB | Du Ying | COB, CEO, Dir | A - Grant | $26.45 | +71.9K | 1.11M | +7% | +$1.90M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2023-06-29 | A | A | 71,880 | $26.45 | 1,110,243 | D | — | — | (F1) Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. (F2) The number of ADSs beneficially owned by the reporting person following this reported transaction corrects inadvertent errors in Column 5 of Table I of the Form 4 for the reporting person filed on June 26, 2023. |